
Paul Taylor
Articles
-
Jun 25, 2024 |
lrb.co.uk | Paul Taylor
Qilin and Synnovis, the two entities involved in the recent ransomware attack that has disabled laboratory services at London hospitals, are very different in many ways but nevertheless have a common purpose: using tech to extract money from healthcare organisations. A standard business model in IT is to offer Software as a Service or SaaS.
-
Mar 21, 2024 |
lrb.co.uk | Paul Taylor
Altmetric is a website that tracks mentions of academic research on social media. Last week, a paper published in Radiology Case Reports leaped to near the top of the charts.
-
Mar 13, 2024 |
lrb.co.uk | Fei-Fei Li |Paul Taylor
Late last year, Rishi Sunak interviewed Elon Musk in front of an invited audience after the Bletchley Park summit on AI safety. He asked Musk what impact AI would have on the labour market, and tried to steer him towards a reassuring answer: AI wouldn’t take away people’s jobs but would create new ones – and politicians like Sunak could help by creating an incredible education system to allow people to take advantage of the new opportunities.
-
Dec 26, 2023 |
advisorpedia.com | Paul Taylor
Health is not made in health systems, it’s made in homes, in communities, in workplaces. So unless we can build horizontal bonds between communities and the kind of expertise and resource in health systems, we can’t really make change. - In a world that has become obsessed with efficiency , speed, and digitisation, a new movement is emerging that is more focused on humanity, personalisation and connection.
-
Nov 20, 2023 |
lrb.co.uk | Paul Taylor
The OpenAI website has a page explaining the company’s peculiar structure. It was founded as a non-profit by a couple of tech companies and a bunch of entrepreneurs including Peter Thiel and Elon Musk. The aim was to secure $1 billion in donations to develop artificial general intelligence (AGI) for the benefit of humanity.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →